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Abstract CpG dinucleotides are suppressed in most vertebrate RNA viruses, including HIV-1,
and introducing CpGs into RNA virus genomes inhibits their replication. The zinc finger antiviral
protein (ZAP) binds regions of viral RNA containing CpGs and targets them for degradation. ZAP
does not have enzymatic activity and recruits other cellular proteins to inhibit viral replication. We
found that KHNYN, a protein with no previously known function, interacts with ZAP. KHNYN
overexpression selectively inhibits HIV-1 containing clustered CpG dinucleotides and this requires
ZAP and its cofactor TRIM25. KHNYN requires both its KH-like domain and NYN endonuclease
domain for antiviral activity. Crucially, depletion of KHNYN eliminated the deleterious effect of
CpG dinucleotides on HIV-1 RNA abundance and infectious virus production and also enhanced the
production of murine leukemia virus. Overall, we have identified KHNYN as a novel cofactor for
ZAP to target CpG-containing retroviral RNA for degradation.
DOI: https://doi.org/10.7554/eLife.46767.001
Introduction
A major component of the innate immune system are cell intrinsic antiviral proteins. These act at
multiple steps in viral replication cycles and some are induced by type I interferons (Schneider et al.,
2014). Many viruses have evolved mechanisms to evade inhibition by these proteins. First, viruses
can encode proteins that counteract specific antiviral factors. Examples of this mechanism in HIV-1
are the accessory proteins Vif and Vpu that counteract APOBEC3 cytosine deaminases and Tetherin,
respectively (Malim and Bieniasz, 2012). Second, viral protein or nucleic acid sequences can evolve
to prevent recognition by antiviral factors. The abundance of CpG dinucleotides is suppressed in
many vertebrate RNA virus genomes and when CpGs are experimentally introduced into picornavi-
ruses or influenza A virus, replication is inhibited (Atkinson et al., 2014; Burns et al., 2009;
Gaunt et al., 2016; Karlin et al., 1994; Tulloch et al., 2014). This shows that CpG suppression in
diverse RNA viruses is required for efficient replication.
CpG dinucleotides are also suppressed in the HIV-1 genome and multiple studies have shown
that they are deleterious for replication (Antzin-Anduetza et al., 2017; Kypr et al., 1989;
Shpaer and Mullins, 1990; Takata et al., 2017; Theys et al., 2018; Wasson et al., 2017). Recently,
the cellular antiviral protein ZAP was shown to bind regions of HIV-1 RNA with high CpG abundance
and target them for degradation, which at least partly explains why this dinucleotide inhibits viral
replication (Takata et al., 2017). ZAP (also known as ZC3HAV1) is a component of the innate
immune response targeting viral RNAs in the cytoplasm to prevent viral protein synthesis (Li et al.,
2015). ZAP inhibits the replication of a diverse range of viruses including retroviruses, alphaviruses,
filoviruses, hepatitis B virus and Japanese encephalitis virus as well as retroelements (Bick et al.,
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2003; Chiu et al., 2018; Gao et al., 2002; Goodier et al., 2015; Mao et al., 2013; Moldovan and
Moran, 2015; Mu¨ller et al., 2007; Takata et al., 2017; Zhu et al., 2011). There are two human ZAP
isoforms, ZAP-L and ZAP-S (Kerns et al., 2008). Both isoforms contain a N-terminal RNA binding
domain containing four CCCH-type zinc finger motifs but ZAP-L also contains a catalytically inactive
C-terminal poly(ADP-ribose) polymerase (PARP)-like domain (Chen et al., 2012; Guo et al., 2004;
Kerns et al., 2008). Importantly, neither isoform of ZAP has nuclease activity and it likely recruits
other cellular proteins to degrade viral RNAs. Identifying and characterizing these cofactors for ZAP
is essential to understand how it restricts viral replication.
ZAP requires the E3 ubiquitin ligase TRIM25 for its antiviral activity against Sindbis virus and HIV-
1 with clustered CpGs (Li et al., 2017; Takata et al., 2017; Zheng et al., 2017). While ZAP has
been reported to interact with several components of the 5’ 3’ and 3’ 5’ RNA degradation path-
ways, depletion of these proteins did not substantially increase infectious virus production for HIV-1
containing clustered CpG dinucleotides (Goodier et al., 2015; Guo et al., 2007; Takata et al.,
2017; Zhu et al., 2011). This suggests that additional proteins may be required for ZAP to inhibit
viral replication. Herein, we identify KHNYN as a cytoplasmic protein that interacts with ZAP and is
necessary for CpG dinucleotides to inhibit HIV-1 RNA and protein abundance.
Results
KHNYN interacts with ZAP and selectively inhibits HIV-1 containing
clustered CpG dinucleotides in a ZAP- and TRIM25-dependent manner
To identify candidate interaction partners for ZAP, a yeast two-hybrid screen was performed for full-
length ZAP-S and ZAP-L using prey fragments from a mixed Pam3CSK4-induced and IFNb-induced
human macrophage cDNA library. Candidate interacting proteins were assigned a Predicted Biologi-
cal Score (PBS) of A to F (Formstecher et al., 2005): A = very high confidence in the interaction,
B = high confidence in the interaction and C = good confidence in the interaction. Scores of D to F
eLife digest Like many viruses, the genetic information of the human immunodeficiency virus (or
HIV for short) is formed of molecules of RNA, which are sequences of building blocks called
nucleotides. Once the virus is inside human cells, a protein called ZAP can identify viral RNAs by
binding to a precise motif, a combination of two nucleotides called CpG. This allows the cell to
destroy the viral RNA, thus preventing the virus from multiplying. However, HIV and other viruses
that infect mammals are often able to ‘hide’ from ZAP because their genetic codes have many fewer
CpG nucleotides than what would be expected by chance.
ZAP by itself does not appear to be able to cut up RNA, so it is thought that it recruits other, as
yet unidentified, proteins to destroy the genome of viruses. Here, Ficarelli et al. used genetic
techniques to identify a new human protein called KHNYN that interacts with ZAP.
First, a new version of the RNA genome of HIV was engineered, which contained higher numbers
of CpGs: this CpG-enriched virus could be inhibited by ZAP in human cells. The experiments
showed that increasing the amount of KHNYN protein led to lower levels of HIV genomes enriched
in CpG. However, increasing the levels of KHNYN protein in mutant cells without ZAP had no effect
on how well CpG-enriched HIV multiplied. CpG-enriched HIV and another related virus with many
CpG nucleotides were able to multiply more successfully in mutant cells lacking the KHNYN protein
than in normal cells. Further experiments also suggested that mutating a region of KHNYN which is
likely to cut RNA prevented it from inhibiting HIV enriched with CpGs.
Artificially manipulating the CpG nucleotide content of viral sequences could help create viruses
useful for human health. For instance, weakened viruses could be designed for use in vaccines.
Some human tumors have decreased levels of ZAP, and it could therefore be possible to build
viruses that healthy cells can destroy, but which could multiply in and kill cancer cells. However,
before these approaches can be developed, exactly how ZAP and KHNYN degrade strands of viral
RNA needs to be characterized.
DOI: https://doi.org/10.7554/eLife.46767.002
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are low confidence interactions, non-specific interactions or proven technical artifacts. For ZAP-S, 11
clones were obtained from 60.4 million tested interactions. 10 of these contained a prey fragment
encoding KHNYN (Figure 1) and had a PBS = A. One clone had an insert encoding MARK3 but this
was in the antisense orientation and therefore did not receive a score. For ZAP-L, two positive clones
were analyzed from 104 million tested interactions. Both of these had an insert encoding KHNYN
and had a PBS = C. KHNYN has two isoforms (KHNYN-1 and KHNYN-2) that contain a N-terminal
KH-like domain and a C-terminal NYN endoribonuclease domain (Figure 1) (Anantharaman and
Aravind, 2006). The selected interaction domain, which is the amino acid sequence shared by all
prey fragments matching KHNYN, comprised amino acids 572–719 of KHNYN-2 for the clones iden-
tified in both screens. A yeast two-hybrid screen was then performed using the same library with full
length KHNYN-2 as the bait. Nine clones were isolated that encode ZAP and these had a PBS = A.
The selected interaction domain was amino acids 4–352, which is present in both isoforms (Figure 1).
Supporting the reproducibility of this interaction, KHNYN has also been identified as a ZAP-interact-
ing factor in large-scale affinity purification–mass spectrometry and in vivo proximity-dependent bio-
tinylation (BioID) screens (Huttlin et al., 2017; Youn et al., 2018).
We first confirmed the interaction between ZAP and KHNYN by co-immunoprecipitation and
found both KHNYN isoforms interacted with both isoforms of ZAP (Figure 2A and B). This interac-
tion was RNase insensitive (Figure 2C). Since ZAP mediates degradation of HIV-1 RNAs with clus-
tered CpG dinucleotides in the cytoplasm (Takata et al., 2017), its cofactors are likely to be
localized in this compartment. Therefore, we analyzed the subcellular localization of KHNYN and
observed that it localizes to the cytoplasm similar to ZAP (Figure 2D). Its localization was not
affected when ZAP was knocked out using CRISPR-Cas9-mediated genome editing.
The mechanisms that allow a virus to escape the innate immune response often have to be inacti-
vated to study the effect of antiviral proteins. For example, HIV-1 Vpu or Vif have to be mutated to
allow Tetherin or APOBEC3 antiviral activity to be analyzed (Malim and Bieniasz, 2012). Since CpG
dinucleotides are suppressed in HIV-1, endogenous ZAP does not target the wild-type virus
(Takata et al., 2017). However, a ZAP-sensitive HIV-1 can be created by introducing CpGs through
synonymous mutations into the env open-reading frame in the viral genome. This makes HIV-1 an
excellent system to study the mechanism of action of this antiviral protein because isogenic viruses
can be analyzed that differ only in their CpG abundance and therefore ZAP-sensitivity (Takata et al.,
2017). To determine if KHNYN overexpression inhibited wild-type HIV-1 or HIV-1 with 36 CpG dinu-
cleotides introduced into env nucleotides 86–561 (HIV-1EnvCpG86-561) (Figure 2—figure supplement
1), each isoform was overexpressed in the context of a single cycle replication assay. As expected,
transfection of the HIV-1EnvCpG86-561 provirus into HeLa cells yielded substantially less infectious virus
than wild-type HIV-1, which was accounted for by reduced expression of Gag and Env proteins
(Figure 2E and F). While KHNYN-1 or KHNYN-2 overexpression decreased wild-type HIV-1 infectiv-
ity by ~5 fold, they decreased HIV-1EnvCpG86-561 infectivity by ~400 fold (Figure 2E). The inhibition of
Figure 1. KHNYN is a ZAP-interacting factor identified by yeast two-hybrid screening. A yeast two-hybrid screen for ZAP-S and ZAP-L interacting
factors identified a region in KHNYN-1 and KHNYN-2. The selected interaction domain (SID) is the amino acid sequence shared by all prey fragments
and is shown in magenta. A reciprocal yeast two-hybrid screen using KHNYN-2 as the bait identified a region in ZAP-S and ZAP-L. The SID is shown in
red.
DOI: https://doi.org/10.7554/eLife.46767.003
Ficarelli et al. eLife 2019;8:e46767. DOI: https://doi.org/10.7554/eLife.46767 3 of 25
Research article Immunology and Inflammation Microbiology and Infectious Disease
Figure 2. KHNYN interacts with ZAP and selectively inhibits HIV-1 containing clustered CpG dinucleotides. (A) Lysates of HEK293T cells transfected
either with pGFP-FLAG, pKHNYN-1-FLAG or pKHNYN-2-FLAG were immunoprecipitated with an anti-ZAP antibody. Post-nuclear supernatants and
immunoprecipitation samples were analyzed by immunoblotting for Hsp90, KHNYN-FLAG and ZAP. * indicates a non-specific band. (B) Lysates of
HEK293T cells transfected either with pGFP-FLAG, pKHNYN-1-FLAG or pKHNYN-2-FLAG were immunoprecipitated with an anti-FLAG antibody. Post-
Figure 2 continued on next page
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infectivity by KHNYN-1 or KHNYN-2 correlated with decreases in Gag expression, Env expression,
and virion production (Figure 2F). Overall, KHNYN appeared to selectively inhibit HIV-1EnvCpG86-561
infectious virus production.
We then determined whether ZAP is necessary for KHNYN to inhibit HIV-1 with clustered CpG
dinucleotides. Control or ZAP knockout cells (Figure 3A) were co-transfected with pHIV-1 or pHIV-
1EnvCpG86-561 and increasing amounts of pKHNYN-1. Wild-type HIV-1 infectious virus production was
not affected by ZAP depletion and HIV-1EnvCpG86-561 infectivity was restored in ZAP knockout cells
(Figures 3B, 0 ng of KHNYN-1), confirming that ZAP is necessary to inhibit HIV-1 with CpGs intro-
duced in env (Takata et al., 2017). At low levels of KHNYN-1 overexpression (such as 62.5 ng), there
was no substantial decrease in infectivity for wild-type HIV-1 while HIV-1EnvCpG86-561 infectivity was
inhibited in a ZAP-dependent manner (Figures 3B and 4A). The decrease in infectivity for HIV-
1EnvCpG86-561 in control cells transfected with pKHNYN-1 correlated with decreases in Gag expres-
sion, Env expression and virion production (Figure 3C).
Next, we analyzed how ZAP and KHNYN regulate HIV-1 genomic RNA abundance in cell lysates
and media. As expected (Takata et al., 2017), HIV-1EnvCpG86-561 genomic RNA abundance was
decreased in control cells but was similar to wild-type HIV-1 in ZAP knockout cells (Figure 4B–C,
compare GFP samples). In control cells, 62.5 ng of KHNYN-1 or KHNYN-2 inhibited HIV-1EnvCpG86-
561 genomic RNA abundance compared to the GFP control (Figure 4B–C). Importantly, KHNYN-1
and KHNYN-2 did not affect wild-type HIV-1 genomic RNA levels and did not substantially inhibit
HIV-1EnvCpG86-561 genomic RNA abundance in ZAP knockout cells. This demonstrates that KHNYN
targets HIV-1 RNA containing clustered CpG dinucleotides in a ZAP-dependent manner.
TRIM25 is required for ZAP’s antiviral activity, although the mechanism by which it regulates ZAP
is unclear (Li et al., 2017; Zheng et al., 2017). To determine if TRIM25 is necessary for the antiviral
activity of KHNYN, 62.5 ng of pKHNYN-1 or pKHNYN-2 was co-transfected with pHIV-1 or pHIV-
1EnvCpG86-561 in control and TRIM25 knockout cells. Both isoforms of KHNYN inhibited HIV-1EnvCpG86-
561 much less potently in TRIM25 knockout cells than control cells and had no effect on wild-type
HIV-1 in either cell line (Figure 5A–B). One possible reason that TRIM25 is necessary for KHNYN
antiviral activity could be that it regulates the interaction between ZAP and KHNYN. We pulled
down KHNYN-FLAG and western blotted for ZAP in control and TRIM25 knockdown cells
(Figure 5C). Both isoforms of KHNYN pulled down ZAP in both cell lines, indicating that TRIM25 is
not required for the interaction between these proteins. Interestingly, KHNYN also pulled down
TRIM25 in control cells (Figure 5C). Therefore, we analyzed whether KHNYN interacted with TRIM25
in control and ZAP knockout cells and observed that both isoforms of KHNYN-FLAG immunoprecipi-
tated TRIM25 in the presence and absence of ZAP (Figure 5D). In sum, KHNYN requires TRIM25 to
inhibit HIV-1 containing clustered CpG dinucleotides, but TRIM25 is not necessary for the interaction
Figure 2 continued
nuclear supernatants and immunoprecipitation samples were analyzed by immunoblotting for HSP90, KHNYN-FLAG and ZAP. * indicates a non-specific
band. (C) Lysates of HEK293T cells transfected with pZAP-L and either pGFP-FLAG, pKHNYN-1-FLAG or pKHNYN-2-FLAG were treated with RNase and
then immunoprecipitated with an anti-FLAG antibody. Post-nuclear supernatants and immunoprecipitation samples were analyzed by immunoblotting
for HSP90, KHNYN-FLAG and ZAP. * indicates a non-specific band. (D) Panels show representative fields for the localization of KHNYN-1-FLAG or
KHNYN-2-FLAG and endogenous ZAP in either 293T Control CRISPR cells expressing a guide RNA targeting LacZ or 293T ZAP guide 1 (ZAP-G1)
CRISPR cells. Cells were stained with an anti-FLAG antibody (red), anti-ZAP antibody (green) and DAPI (blue). The scale bar represents 10 mM. (E–F)
HeLa cells were transfected with 500 ng pHIV-1 or pHIV-1EnvCpG86-561 and 500 ng of pGFP-FLAG, pKHNYN-1-FLAG or pKHNYN-2-FLAG. See also
Figure 2—figure supplement 1. Culture supernatants were used to infect TZM-bl reporter cells to measure infectivity (E). The bar charts show the
average values of three independent experiments normalized to the value obtained for HeLa cells co-transfected with pHIV-1 and pGFP-FLAG. Data
are represented as mean ± SD. *p<0.05 as determined by a two-tailed unpaired t-test. p-values for GFP verses KHNYN-1 and KHNYN-2 for wild-type
HIV-1 are 2.76  10 9 and 2.20  10 6, respectively. p-Values for GFP verses KHNYN-1 and KHNYN-2 for HIV-1EnvCpG86-561 are 1.50  10
 3 and 1.51 
10 3, respectively. Gag expression in the media as well as Gag, Hsp90, Env, Actin, KHNYN-FLAG and GFP-FLAG expression in the cell lysates was
detected using quantitative immunoblotting (F).
DOI: https://doi.org/10.7554/eLife.46767.004
The following figure supplement is available for figure 2:
Figure supplement 1. HIV-1EnvCpG86-561 contains 36 introduced CpG dinucleotides.
DOI: https://doi.org/10.7554/eLife.46767.005
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Figure 3. ZAP is required for KHNYN to inhibit infectious virion production for HIV-1 with clustered CpG dinucleotides. (A) ZAP, TRIM25 and Actin
expression in HeLa cells, HeLa Control CRISPR cells (expressing a guide RNA targeting the firefly luciferase gene), HeLa ZAP CRISPR guide 1 (ZAP-G1)
cells and HeLa TRIM25 CRISPR guide 1 (TRIM25-G1) cells were detected using quantitative immunoblotting. (B–C) HeLa Control CRISPR cells or ZAP-
G1 CRISPR cells were transfected with 500 ng pHIV-1 or pHIV-1EnvCpG86-561 and 500 ng of pGFP-FLAG or 31.25 ng, 62.5 ng, 125 ng, 250 ng or 500 ng
pKHNYN-1-FLAG plus the amount of pGFP-FLAG required to make 500 ng total. Culture supernatants from the cells were used to infect TZM-bl
reporter cells (B). Each point shows the average value of three independent experiments normalized to the value obtained for HeLa Control CRISPR
Figure 3 continued on next page
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between ZAP and KHNYN. Furthermore, ZAP, KHNYN and TRIM25 appear to be in a complex
together.
The KH-like and NYN domains are necessary for KHNYN antiviral
activity
As its name implies, KHNYN contains a KH-like domain and a NYN domain (Figure 6A). The KH-like
domain differs from canonical KH domains due to a potential small metal chelating module contain-
ing two cysteines and a histidine inserted into the central region of the domain (Anantharaman and
Aravind, 2006). Since this has diverged substantially from a standard KH domain, it has also been
called a CGIN1 domain and is only known to be present in two other proteins (Marco and Marı´n,
2009). While most KH domains bind nucleic acids (Nicastro et al., 2015), the insertion in the KH-like
domain in KHNYN may disrupt RNA binding and indicate that it has a different function. To analyze
the functional importance of the KH-like domain, we deleted it and found that KHNYN-1DKH and
KHNYN-2DKH had reduced antiviral activity compared to the wild-type protein (Figure 6B–C). These
mutant proteins localized to the cytoplasm and formed foci that were not present for wild-type
KHNYN-1 or KHNYN-2 (Figure 6—figure supplement 1).
NYN domains have endonuclease activity and belong to the PIN nuclease domain superfamily.
There are at least eight human proteins with a potentially active NYN domain and they have been
structurally characterized in several proteins including ZC3H12A and MARF1 (Matelska et al., 2017;
Matsushita et al., 2009; Nishimura et al., 2018; Xu et al., 2012; Yao et al., 2018). These domains
contain a negatively charged active site with four aspartic acid residues coordinating a magnesium
ion, which activates a water molecule for nucleophilic attack of the phosphodiester group on the tar-
get RNA. Mutation of these acidic residues inhibits nuclease activity by disrupting the bonds that
directly or indirectly interact with the magnesium ion. ZC3H12A (also known as MCPIP1 and Reg-
nase) is a RNA binding protein that, similar to ZAP, contains a CCCH zinc finger domain and
degrades cellular and viral RNAs (Takeuchi, 2018). The NYN domain in ZC3H12A has 56% identity
to the NYN domain in KHNYN (Figure 6—figure supplement 2A). ZC3H12A containing a D141N
mutation in the NYN domain had decreased endonuclease activity and did not degrade RNA con-
taining the IL-6 3’ UTR (Matsushita et al., 2009). MARF1 is required for meiosis and retrotransposon
silencing in oocytes and a D426A/D427A mutation inhibited its endoribonuclease activity
(Nishimura et al., 2018; Su et al., 2012). We made these equivalent mutations in KHNYN
(Figure 6A and Figure 6—figure supplement 2B) and tested their ability to inhibit HIV-1EnvCpG86-561
gene expression and infectious virus production (Figure 6B–C). KHNYN-1 D443N and KHNYN-2
D484N had substantially decreased activity against HIV-1EnvCpG86-561. Strikingly, KHNYN-1 D524A/
D525A and KHNYN-2 D565A/D566A had no antiviral activity even though they were expressed at
similar levels to the wild-type KHNYN. KHNYN proteins with mutations in the NYN domain localized
to the cytoplasm, indicating that disruption of this domain’s activity did not substantially affect their
subcellular localization (Figure 6—figure supplement 1).
KHNYN is necessary for CpG dinucleotides to inhibit HIV-1 RNA and
protein expression
To determine if KHNYN is required for CpG dinucleotides to inhibit infectious HIV-1 production, we
depleted it using CRISPR-Cas9-mediated genome editing using single-guide RNAs (sgRNAs) target-
ing two independent sequences in KHNYN (Figure 7A-C = sgRNA 1, Figure 7—figure supplement
1 = sgRNA 2). We were unable to identify an antibody that detected endogenous KHNYN. However,
FLAG-tagged KHNYN-1 and KHNYN-2 were depleted in the bulk population of cells expressing
each sgRNA as well as two clonal cell lines from each bulk population (Figure 7A and Figure 7—fig-
ure supplement 1A). Importantly, when the CRISPR PAM sequence was mutated in the KHNYN
plasmids, KHNYN-1 and KHNYN-2 were no longer depleted. The relevant region of KHNYN was
Figure 3 continued
cells co-transfected with pHIV-1 and pGFP-FLAG. Data are represented as mean ± SD. Gag expression in the media as well as Gag, Hsp90, Env, Actin,
KHNYN-FLAG and GFP-FLAG expression in the cell lysates was detected using quantitative immunoblotting (C).
DOI: https://doi.org/10.7554/eLife.46767.006
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Figure 4. ZAP is required for KHNYN to inhibit genomic RNA abundance for HIV-1 with clustered CpG
dinucleotides. (A–C) HeLa Control CRISPR cells or ZAP-G1 CRISPR cells were transfected with 500 ng pHIV-1 or
pHIV-1EnvCpG86-561 and 500 ng of pGFP-FLAG or 62.5 ng pKHNYN-1/2-FLAG plus 437.5 ng of pGFP-FLAG. Culture
supernatants from the cells were used to infect TZM-bl reporter cells (A). The bar chart shows the average value of
Figure 4 continued on next page
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also sequenced to identify the insertion or deletion in the bulk populations as well as the clones and
genetic alterations that inactive the protein were identified in each (Figure 7—figure supplement
2). These KHNYN CRISPR cells were then transfected with pHIV-1 or pHIV-1EnvCpG86-561. In the
KHNYN CRISPR cells, the CpG dinucleotides in HIV-1EnvCpG86-561 no longer inhibited infectious virus
production, Gag expression or Env expression (Figure 7B–C, Figure 7—figure supplement 1B–C).
Wild-type HIV-1 Gag expression, Env expression and infectious virus production was not altered in
the KHNYN CRISPR cells compared to the control cells. Overall, the KHNYN CRISPR cells phenocop-
ied the ZAP CRISPR cells (Figure 7B–C).
We also analyzed the effect of KHNYN depletion on murine leukemia virus (MLV). While most ret-
roviruses are suppressed in CpG abundance, the degree of this suppression varies between the dif-
ferent genera (Berkhout et al., 2002). HIV-1NL4-3 is highly suppressed (9 CpGs/kb; 0.2 observed/
expected), which is conserved in HIV-1 (Berkhout et al., 2002; Kypr et al., 1989; Shpaer and Mul-
lins, 1990). However, the CpG abundance in MLV is much less suppressed (35 CpGs/kb; 0.5
observed/expected) and ZAP was initially identified as an antiviral protein based on its ability to
bind MLV RNA and target it for degradation (Gao et al., 2002; Guo et al., 2004; Guo et al., 2007).
To determine if KHNYN inhibits MLV, control, ZAP and KHNYN CRISPR cells were co-transfected
with pMLV, p2.87 Vpu (which encodes a highly active HIV-1 Vpu to counteract endogenous Tetherin
expression in these cells [Neil et al., 2008; Pickering et al., 2014]) and pGFP. MLV Gag expression
and virion production were measured by immunoblotting. Since ZAP is a type I interferon-stimulated
gene (Shaw et al., 2017), MLV Gag expression and virion production were also analyzed after type I
interferon treatment. There was a small but reproducible increase in MLV Gag expression and virion
production in the ZAP and KHNYN CRISPR cells in the absence of type I interferon (Figure 7D).
However, after type I interferon treatment, MLV virion production was decreased to almost unde-
tectable levels in the control CRISPR cells but was substantially higher in the ZAP and KHNYN
CRISPR cells (Figure 7E).
The Sindbis virus genome is not substantially depleted in CpG dinucleotides (58 CpGs/kb; 0.9
observed/expected) and is restricted by ZAP (Bick et al., 2003). However, unlike retroviruses, the
predominant ZAP antiviral activity for alphaviruses is to inhibit viral RNA translation, although there
may be an additional effect on RNA stability (Bick et al., 2003; Kozaki et al., 2015). As expected
(Bick et al., 2003; Kozaki et al., 2015; Li et al., 2017; Zheng et al., 2017), depletion of TRIM25
and ZAP substantially increased Sindbis virus replication (Figure 7—figure supplement 3). In con-
trast, there was no substantial increase in Sindbis virus replication in the KHNYN CRISPR cells. Thus,
KHNYN appears to be required for the restriction of retroviral genomes, but not all ZAP-sensitive
RNA viruses.
We then analyzed HIV-1 genomic RNA abundance in the KHNYN CRISPR cells. Similar to HIV-1
protein expression and infectivity, HIV-1EnvCpG86-561 genomic RNA abundance was similar in the cell
lysate and media to wild-type HIV-1 (Figure 8A and C), indicating that the CpG dinucleotides no
longer inhibited RNA abundance. As expected, nef mRNA abundance was not affected by the
Figure 4 continued
five independent experiments normalized to the value obtained for HeLa Control CRISPR cells co-transfected with
pHIV-1 and pGFP-GFP. Data are represented as mean ± SD. *p<0.05 as determined by a two-tailed unpaired
t-test. p-values for GFP verses KHNYN-1 and KHNYN-2 for HIV-1EnvCpG86-561 in Control cells are 6.78  10
 3 and
7.20  10 3, respectively. p-Values for GFP verses KHNYN-1 and KHNYN-2 for HIV-1EnvCpG86-561 in ZAP-G1 cells
are 3.22  10 1 and 5.33  10 1, respectively. RNA was extracted from cell lysates (B) and media (C) and genomic
RNA (gRNA) abundance was quantified by qRT-PCR. The bar charts show the average value of five independent
experiments normalized to the value obtained for HeLa Control CRISPR cells co-transfected with pHIV-1 and
pGFP-GFP. Data are represented as mean ± SD. *p<0.05 as determined by a two-tailed unpaired t-test. For HIV-
1EnvCpG86-561 genomic RNA in Control cell lysates, the GFP verses KHNYN-1 and KHNYN-2 p-values are 2.14 
10 2 and 2.30  10 2, respectively. For HIV-1EnvCpG86-561 genomic RNA in ZAP-G1 cell lysates, the GFP verses
KHNYN-1 and KHNYN-2 p-values are 1.01  10 1 and 4.33  10 2, respectively. For HIV-1EnvCpG86-561 genomic
RNA in Control cell media, p-values for GFP verses KHNYN-1 and KHNYN-2 are 8.97  10 4 and 9.38  10 4,
respectively. For HIV-1EnvCpG86-561 genomic RNA in ZAP-G1 cell media, p-values for GFP verses KHNYN-1 and
KHNYN-2 are 6.09  10 1 and 1.87  10 1, respectively.
DOI: https://doi.org/10.7554/eLife.46767.007
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Figure 5. TRIM25 is required for KHNYN to inhibit HIV-1 with clustered CpG dinucleotides. (A–B) HeLa Control CRISPR cells or TRIM25-G1 CRISPR
cells were transfected with 500 ng pHIV-1 or pHIV-1EnvCpG86-561 and 500 ng of pGFP-FLAG or 62.5 ng pKHNYN-1-FLAG or pKHNYN-2-FLAG plus 437.5
ng of pGFP-FLAG. Culture supernatants from the cells were used to infect TZM-bl reporter cells (A). The bar charts show the average value of three
independent experiments normalized to the value obtained for HeLa Control CRISPR cells co-transfected with pHIV-1 and pGFP-FLAG. Data are
Figure 5 continued on next page
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introduction of CpG dinucleotides in env or by KHNYN depletion since it is a fully spliced mRNA
that does not contain the introduced CpGs (Figure 8B). The wild-type HIV-1 genomic RNA abun-
dance was not altered in the KHNYN CRISPR cells compared to the control cells, further showing
the specific effect of KHNYN for viral RNA containing CpG dinucleotides.
To determine the specificity of the KHNYN knockdown, we titrated CRISPR-resistant pKHNYN-1
or pKHNYN-2 into the KHNYN CRISPR cells. Even very low levels of KHNYN-1 or KHNYN-2 restored
selective inhibition of HIV-1EnvCpG86-561 in these cells (Figure 9A–B) and KHNYN-1 was consistently
slightly more active than KHNYN-2. This shows that both isoforms are capable of inhibiting infectious
virus production of HIV-1 containing clustered CpG dinucleotides. We also analyzed whether KHNYN
with the KH-like domain deleted or the putative catalytic mutations in the NYN domain could inhibit
HIV-1EnvCpG86-561 infectious virus production in the CRISPR cells. Expression of 31.25 ng of KHNYN-1
in the KHNYN CRISPR cells inhibited HIV-1EnvCpG86-561 (Figure 9C–D) and all of the mutations sub-
stantially reduced KHNYN antiviral activity. In sum, endogenous KHNYN is required for CpG dinu-
cleotides to inhibit HIV-1 infectious virus production.
Discussion
Several members of the CCCH zinc finger domain protein family target viral and/or cellular mRNAs
for degradation (Fu and Blackshear, 2017). For example, ZC3H12A degrades pro-inflammatory
cytokine mRNAs and also inhibits the replication of several viruses, including HIV-1 and hepatitis C
virus (Lin et al., 2013; Lin et al., 2014; Liu et al., 2013; Matsushita et al., 2009). It contains a
CCCH zinc finger domain as well as a NYN endonuclease domain, which allows it to degrade specific
RNAs (Matsushita et al., 2009; Xu et al., 2012). ZAP has four CCCH zinc finger domains and specif-
ically interacts with CpG dinucleotides in RNA (Gao et al., 2002; Guo et al., 2004; Takata et al.,
2017). However, it does not contain nuclease activity. While ZAP has been reported to directly or
indirectly interact with components of the 5’ 3’ and 3’ 5’ degradation pathways including DCP1-
DCP2, XRN1, PARN and the exosome, knockdown of several proteins in these pathways did not sub-
stantially rescue infectious virus production of HIV-1 containing clustered CpG dinucleotides
(Goodier et al., 2015; Guo et al., 2007; Takata et al., 2017; Zhu et al., 2011). Therefore, we
hypothesized that ZAP may interact with additional unidentified proteins that regulate viral RNA
degradation.
Herein, we have identified that KHNYN is an essential ZAP cofactor that inhibits HIV-1 gene
expression and infectious virus production when the viral RNA contains clustered CpG dinucleotides.
KHNYN overexpression inhibits genomic RNA abundance, Gag expression, Env expression and
infectious virus production for HIV-1 containing clustered CpG dinucleotides. This activity requires
ZAP and TRIM25. Furthermore, depletion of KHNYN using CRISPR-Cas9 specifically increased geno-
mic RNA abundance, Gag expression, Env expression and infectious virus production for HIV-1 con-
taining clustered CpG dinucleotides. This indicates that KHNYN is essential for CpG dinucleotides to
inhibit infectious virus production. Similarly, KHNYN depletion increased MLV Gag expression and
virion production. However, Sindbis virus replication was not substantially increased in the KHNYN
knockout cells. The difference between the requirement for KHNYN to inhibit retroviruses versus
Sindbis virus may be because the antiviral effect for retroviruses is predominantly at the level of RNA
stability and for alphaviruses it is predominately at the level of translation (Bick et al., 2003;
Figure 5 continued
represented as mean ± SD. *p<0.05 as determined by a two-tailed unpaired t-test. p-values for GFP verses KHNYN-1 and KHNYN-2 for HIV-1EnvCpG86-
561 in Control cells are 8.95  10
 4 and 5.42  10 4, respectively. p-values for GFP verses KHNYN-1 and KHNYN-2 for HIV-1EnvCpG86-561 in TRIM25-G1
CRISPR cells are 1.78  10 3 and 1.01  10 4, respectively. Gag expression in the media as well as Gag, Hsp90, Env, Actin, KHNYN-FLAG and GFP-
FLAG expression in the cell lysates was detected using quantitative immunoblotting (B). (C) Lysates of Control and TRIM25 CRISPR HEK293T cells
transfected with pGFP-FLAG, pKHNYN-1-FLAG or pKHNYN-2-FLAG were immunoprecipitated with an anti-FLAG antibody. Post-nuclear supernatants
and immunoprecipitation samples were analyzed by immunoblotting for HSP90, KHNYN-FLAG, TRIM25 and ZAP. The blots are representative of two
independent experiments. (D) Lysates of Control and ZAP CRISPR HEK293T cells transfected with pGFP-FLAG, pKHNYN-1-FLAG or pKHNYN-2-FLAG
were immunoprecipitated with an anti-FLAG antibody. Post-nuclear supernatants and immunoprecipitation samples were analyzed by immunoblotting
for HSP90, KHNYN-FLAG, TRIM25 and ZAP. * indicates a non-specific band. The blots are representative of two independent experiments.
DOI: https://doi.org/10.7554/eLife.46767.008
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Figure 6. The KH and NYN domains are necessary for KHNYN antiviral activity. (A) Schematic of KHNYN-1 and KHNYN-2 domains and mutations in
the NYN domain. (B–C) HeLa cells were transfected with 500 ng pHIV-1 or pHIV-1EnvCpG86-561 and either 500 ng of pGFP-FLAG or 62.5 ng pKHNYN-1/2-
FLAG and 437.5 ng of pGFP-FLAG. Culture supernatants were used to infect TZM-bl reporter cells to measure infectivity (B). The bar charts show the
average values of three independent experiments normalized to the value obtained for HeLa cells co-transfected with pHIV-1 and pGFP-FLAG. Data
Figure 6 continued on next page
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Gao et al., 2002; Guo et al., 2004; Guo et al., 2007; MacDonald et al., 2007). A mechanistic
explanation for why the major antiviral effect of ZAP appears to be promoting RNA degradation for
some viruses and inhibiting translation for other viruses remains unclear, although ZAP has been
reported to inhibit translation initiation by interfering with the interaction between eIF4A and eIF4G
(Zhu et al., 2012). Therefore, KHNYN may not be required for ZAP to inhibit translation.
We hypothesize that a complex containing ZAP and KHNYN binds HIV-1 CpG-containing RNA.
ZAP and KHNYN could directly interact to form a heterodimer or there could be other factors medi-
ating this interaction. The interaction between ZAP and KHNYN has been detected using several dif-
ferent assays including yeast-two-hybrid, co-immunoprecipitation, affinity purification–mass
spectrometry (Huttlin et al., 2017) and BioID (Youn et al., 2018). If there is an unknown factor
mediating this interaction, it would have to present in the yeast-two-hybrid assay. It remains unclear
how TRIM25 regulates ZAP, but it is not required for ZAP and KHNYN to interact. Interestingly,
TRIM25 co-immunoprecipitates with KHNYN and the ZAP antiviral complex may simultaneously con-
sist of all three proteins. ZAP and TRIM25 are interferon-stimulated genes while KHNYN is not
induced by interferon in human cells (Shaw et al., 2017). Whether KHNYN is regulated by type I
interferons or viral infection in a different way, such as post-translational modification, is not known.
The zinc finger RNA binding domains in ZAP could target KHNYN to CpG regions in viral RNA.
This would allow the endonuclease domain in KHNYN to cleave this RNA, thereby inhibiting viral
RNA abundance. Conceptually, the ZAP-KHNYN complex could function similarly to ZC3H12A, but
with the RNA binding and endonuclease domains divided between the two proteins. The NYN
domain in KHNYN could cleave HIV-1 RNA containing CpG dinucleotides similar to how ZC3H12A
cleaves a specific site in the 3’ UTR of the IL-6 mRNA (Matsushita et al., 2009). While we do not yet
have evidence that the NYN domain in KHNYN is an active endonuclease domain, it is highly con-
served with the active NYN domain in ZC3H12A and is required for KHNYN antiviral activity. Strik-
ingly, mutation of two conserved aspartic acid residues in the NYN domain predicted to coordinate
a magnesium ion necessary for nucleophilic attack of the target RNA eliminated KHNYN antiviral
activity. However, biochemical and structural studies will be necessary to determine the specific
nature of the interaction between ZAP, KHNYN, TRIM25 and RNA and how these interactions pro-
mote viral RNA degradation.
An increasingly common theme for RNA decay is that endonucleic and exonucleic degradation
pathways work together to fully degrade RNAs. For example, nonsense-mediated decay (NMD) tar-
gets mRNAs that do not efficiently terminate translation at the stop codon and uses up to four
mechanisms to degrade these mRNAs: endonucleic cleavage, deadenylation, decapping and exonu-
cleic degradation (Lykke-Andersen and Jensen, 2015). In this pathway, the endonuclease SMG6
interacts with the core regulatory protein UPF1 and cleaves mRNA near a premature termination
codon. The 5’ and 3’ cleavage fragments are then degraded by the 5’ 3’ exonuclease XRN1 and
the 3’ 5’ exonuclease exosome complex. The CCR4–NOT deadenylase complex and DCP1-DCP2
decapping complex are recruited by proteins in the NMD complex including UPF1, SMG5, SMG7
and PNRC2. Similarly, the 5’ 3’ and 3’ 5’ degradation pathway components previously shown to
interact with ZAP could work in conjunction with KHNYN-mediated endonucleic decay
(Goodier et al., 2015; Guo et al., 2007; Zhu et al., 2011). In this model, KHNYN would initiate
cleavage of the viral RNA and the exonucleic pathways would then degrade the resulting RNA
Figure 6 continued
are represented as mean ± SD. *p<0.05 as determined by a two-tailed unpaired t-test. p-values for KHNYN-1 versus DKH-KHNYN-1, D443N-KHNYN-1,
and D524A/D525A-KHNYN-1 for HIV-1EnvCpG86-561 are 1.31  10
 2, 5.22  10 3, and 1.26  10 3, respectively. p-values for KHNYN-2 versus DKH-
KHNYN-2, D443N-KHNYN-2, and D524A/D525A-KHNYN-2 for HIV-1EnvCpG86-561 are 2.88  10
 2, 3.26  10 2, and 2.56  10 4, respectively. Gag
expression in the media as well as Gag, Hsp90, Env, Actin, KHNYN-1/2-FLAG and GFP-FLAG expression in the cell lysates was detected using
quantitative immunoblotting (C). See also Figure 6—figure supplements 1 and 2.
DOI: https://doi.org/10.7554/eLife.46767.009
The following figure supplements are available for figure 6:
Figure supplement 1. KHNYN mutant proteins localize to the cytoplasm.
DOI: https://doi.org/10.7554/eLife.46767.010
Figure supplement 2. NYN domain alignment.
DOI: https://doi.org/10.7554/eLife.46767.011
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Figure 7. KHNYN depletion increases infectious virus production for HIV-1 with clustered CpG dinucleotides and MLV Gag expression. (A) 100 ng
pKHNYN-1-FLAG, pKHNYN-2-FLAG, pKHNYN-1-FLAG with a mutation in the PAM that prevents it from being targeted by KHNYN guide 1 (pKHNYN-
1-CRG1-FLAG) or pKHNYN-2-CRG1-FLAG plus 400 ng of pGFP were transfected into HeLa Control CRISPR cells, KHNYN guide 1 (KHNYN-G1) CRISPR
bulk cells or KHNYN-G1 CRISPR single cell clones A and B. KHNYN-FLAG abundance was measured by quantitative western blotting. (B–C) HeLa
Control CRISPR cells, ZAP-G1 CRISPR cells, KHNYN guide 1 (KHNYN-G1) CRISPR bulk cell population or single cell clones A and B were transfected
with 500 ng pHIV-1 or pHIV-1EnvCpG86-561 and 500 ng pGFP. Culture supernatants were used to infect TZM-bl reporter cells to measure infectivity (B).
The bar charts show the average value of six independent experiments normalized to the value obtained for HeLa Control CRISPR cells co-transfected
with pHIV-1 and pGFP. Data are represented as mean ± SD. *p<0.05 as determined by a two-tailed unpaired t-test. p-values for HIV-1EnvCpG86-561 in
Control cells versus ZAP-G1, KHNYN-G1 Bulk, KHNYN-G1 Clone A, and KHNYN-G1 Clone B CRISPR cells are 8.23  10 6, 2.81  10 6, 1.60  10 6,
and 2.24  10 6, respectively. Gag expression in the media as well as Gag, Hsp90, Env, and Actin expression in the cell lysates was detected using
Figure 7 continued on next page
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fragments. Identifying the full complement of ZAP-interacting factors and characterizing how these
target viral RNAs for degradation will be an exciting area of future investigation.
Another important area of future research will be to determine how KHNYN and other cellular
proteins that contain an NYN endonuclease domain inhibit the replication of different viruses in dif-
ferent cell types with and without interferon treatment. The interferon-stimulated gene N4BP1,
which is a KHNYN paralog (Anantharaman and Aravind, 2006), was recently identified to geneti-
cally interact with ZAP in a CRISPR-based screen to identify interferon-induced antiviral proteins tar-
geting HIV-1 (OhAinle et al., 2018). In the monocytic THP-1 cell line, depletion of N4BP1 led to a
small increase in wild-type HIV-1 replication. However, N4BP1 depletion did not inhibit replication of
the alphavirus Semliki Forest virus, indicating that it may have a virus specific effect. While ZAP inhib-
its a range of viruses in different cell types, it remains unknown whether its cofactor requirements
are cell type dependent. In this study, we have analyzed the antiviral activity of ZAP and KHNYN on
HIV-1 and MLV in HeLa cells, but the role of NYN domain-containing proteins in targeting viral RNAs
for degradation may be an important component of the antiviral innate immune response in a variety
of cell types. It will also be interesting to determine if proteins containing an endonuclease domain
other than KHNYN interact with CCCH zinc finger proteins to mediate antiviral activity. There are 57
human CCCH zinc finger proteins (Fu and Blackshear, 2017). At least 15 of these proteins are
known to promote RNA decay and, including ZAP, six human CCCH zinc finger proteins are antiviral
(Fu and Blackshear, 2017). Identifying the full complement of CCCH zinc finger proteins that inhibit
viral replication and determining whether they require proteins containing endonuclease domains




All primers were ordered from Eurofins. Polymerase chain reactions (PCR) for cloning steps were
performed with Phusion High Fidelity polymerase (New England Biolabs). KHNYN-2
(NM_001290256) was synthesized by GenScript. KHNYN-1 was cloned by amplifying the nucleotides
123–2157 from KHNYN-2 and sub-cloning the PCR product into the pcDNA3.1 (+) backbone using
the HindIII site in the vector and SbfI site in the KHNYN open reading frame. KHNYN-1 DKH,
D443N, D524A/D525A, -CRG1, -CRG2 and KHNYN-2 DKH, D484N, D565A/D566A, -CRG1, -CRG2
were generated via overlap extension PCR and subsequently sub-cloning the PCR product into the
pcDNA3.1 (+) backbone as described above. pGFP-FLAG was cloned by amplifying GFP from
pcDNA3.1-GFP (Swanson et al., 2010) and cloning it into pcDNA3.1. Diagnostic restriction enzyme
digestion and DNA sequencing (Eurofins, Genewiz) was used to ensure the correct identity of modi-
fied sequences inserted into plasmids. pHIV-1NL4-3 contains the HIV-1 provirus in the pGL4 vector
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quantitative immunoblotting (C). (D–E) HeLa Control CRISPR cells, ZAP-G1 CRISPR cells and KHNYN G1 CRISPR clone B were transfected with 650 ng
pMLV, 250ng p2.87 Vpu and 100 ng pGFP. Gag expression in the media (D) as well as Gag and Hsp90 expression in the cell lysates (E) was detected
using quantitative immunoblotting. The bar charts show the average value of five independent experiments normalized to the value obtained for HeLa
Control CRISPR cells. Data are represented as mean ± SD. *p<0.05 as determined by a two-tailed unpaired t-test. p-values for virions from Control cells
versus ZAP-G1 and KHNYN-G1 Clone B CRISPR cells without type I IFN are 1.28  10 3 and 1.50  10 3, respectively, and 4.17  10 3 and 1.92  10 2
with type I IFN treatment. p-values for the cell lysates from Control cells versus ZAP-G1 and KHNYN-G1 Clone B CRISPR cells are 1.78  10 2 and 8.01
 10 3 without type I interferon, respectively, and 6.37  10 2 and 1.73  10 4 with type I interferon treatment.
DOI: https://doi.org/10.7554/eLife.46767.012
The following figure supplements are available for figure 7:
Figure supplement 1. KHNYN is necessary for CpG dinucleotides to inhibit HIV-1 infectious virus production.
DOI: https://doi.org/10.7554/eLife.46767.013
Figure supplement 2. CRISPR-Cas9-induced mutations in KHNYN.
DOI: https://doi.org/10.7554/eLife.46767.014
Figure supplement 3. KHNYN depletion does not substantially increase Sindbis virus replication.
DOI: https://doi.org/10.7554/eLife.46767.015
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(Antzin-Anduetza et al., 2017). To generate HIV-1EnvCpG86-561, we synthesized a HIV-1NL4-3 EcoRI/
StuI DNA fragment with synonymous mutations that inserted 36 CpG dinucleotides into env (Fig-
ure 2—figure supplement 1). This DNA fragment was digested with EcoRI and StuI and inserted
into the corresponding sites of pHIV-1NL4-3. pMLV is pNCS, which contains the Moloney murine leu-
kemia virus provirus DNA (Yueh and Goff, 2003). pCR3.1 2.87 Vpu contains the HA-tagged codon-
optimized HIV-1 Vpu 2.87 (Pickering et al., 2014).
Cell lines
HeLa and HEK293T cells were obtained from the ATCC and were maintained in high glucose DMEM
supplemented with GlutaMAX, 10% fetal bovine serum, 20 mg/mL gentamicin or 100 U/ml penicillin
and 100 mg/ml streptomycin and incubated with 5% CO2 at 37˚C. BHK-21 cells were obtained from
ATCC and were maintained in GMEM supplemented with 10% fetal bovine serum, 10% tryptose
Figure 8. KHNYN is necessary for CpG dinucleotides to inhibit HIV-1 genomic RNA expression. (A–C) HeLa Control CRISPR cells, ZAP-G1 CRISPR cells,
KHNYN-G1 CRISPR bulk cells or two independent clones were transfected with 500 ng pHIV-1 or pHIV-1EnvCpG86-561 and 500 ng pGFP-FLAG. RNA was
extracted from cell lysates (A–B) and media (C). Genomic RNA (gRNA) (A, C) or nef mRNA (B) abundance was quantified by qRT-PCR. The bar charts
show the average value of three independent experiments normalized to the value obtained for HeLa Control CRISPR cells co-transfected with pHIV-1
and pGFP-FLAG. Data are represented as mean ± SD. *p<0.05 as determined by a two-tailed unpaired t-test. p-values for HIV-1EnvCpG86-561 genomic
RNA in Control cell versus ZAP-G1, KHNYN-G1 Bulk, KHNYN-G1 Clone A, and KHNYN-G1 Clone B CRISPR cell lysates are 2.98  10 2, 3.70  10 2,
4.26  10 2, and 1.30  10 4, respectively. p-Values for HIV-1EnvCpG86-561nef mRNA in Control cell versus ZAP-G1, KHNYN-G1 Bulk, KHNYN-G1 Clone
A, and KHNYN-G1 Clone B CRISPR cell lysates are 0.29, 0.54, 0.90 and 0.42, respectively. p-Values for HIV-1EnvCpG86-561 genomic RNA in Control cell
versus ZAP-G1, KHNYN-G1 Bulk, KHNYN-G1 Clone A, and KHNYN-G1 Clone B CRISPR cell media are 1.65  10 2, 8.64  10 3, 2.82  10 3, and 3.54
 10 4, respectively.
DOI: https://doi.org/10.7554/eLife.46767.016
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Figure 9. Deletion of the KH-like domain or mutations in the NYN domain in KHNYN prevent reconstitution of CpG-dependent inhibition of HIV-1
infectious virus production in KHNYN CRISPR cells. (A–B) HeLa KHNYN-G1 CRISPR clone B cells were transfected with 500 ng pHIV-1 or pHIV-
1EnvCpG86-561 and 500 ng of pGFP-FLAG or 31.25 ng, 62.5 ng, 125 ng, 250 ng or 500 ng of pKHNYN-1-CRG1-FLAG or pKHNYN-2-CRG1-FLAG plus the
amount of pGFP-FLAG required to make 500 ng total. Culture supernatants from the cells were used to infect TZM-bl reporter cells (A). Each point
Figure 9 continued on next page
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phosphate broth, and penicillin/streptomycin. Their identity has not been authenticated and they are
routinely tested for mycoplasma contamination with all tests negative. CRISPR guides targeting the
firefly luciferase gene, lacZ gene, human TRIM25, ZAP (also known as ZC3HAV1), and KHNYN genes
were cloned into BsmBI restriction enzyme sites in the lentiviral vector genome plasmid
lentiCRISPRv2 (Sanjana et al., 2014). The CRISPR guide sequences are: LacZ-G1: 5’- CGA TTA AGT
TGG GTA ACG CC  3’, Luciferase-G1: 5’-CTT TAC CGA CGC ACA TAT CG-3’, TRIM25-G1: 5’-
GAG CCG GTC ACC ACT CCG TG  3’, ZAP-G1: 5’- ACT TCC ATC TGC CTT ACC GG  3’,
KHNYN-G1: 5’-GGG GGT GAG CGT CCT TCC GA-3’, KHNYN-G2: 5’-CAG ACA CCG CAA AGC
GAT CT-3’. LentiCRISPR vectors encoding guide RNAs targeting KHNYN or LacZ were produced in
HEK293T cells seeded in a 10 cm dish and transfected using 100 ul PEI with 8 mg of lentiCRISPRv2-
Guide, 8 mg of pCRV1-HIV-Gag Pol (Neil et al., 2008) and 4 mg of pCMV-VSV-G (Neil et al., 2008).
Lentiviral vectors encoding guide RNAs targeting ZAP or TRIM25 were produced by transfecting
HEK293T cells seeded in a six-well plate using 10 ml PEI with 0.5 mg pVSV-G (Fouchier et al., 1997),
1.0 mg pCMVDR8.91 (Zufferey et al., 1997), and 1.0 mg LentiCRISPRv2-Guide. Virus containing
supernatant was harvested 48 hr after transfection, rendered cell-free via filtration through 0.45 mM
filters (Millipore) and used to transduce HeLa or HEK293T cells followed by selection in puromycin.
Yeast two-hybrid screen
The yeast two-hybrid screen was performed by Hybrigenics Services, S.A.S., Paris, France (http://
www.hybrigenics-services.com). Full length ZAP-S, ZAP-L and KHNYN-2 were PCR-amplified and
cloned into pB27 as a C-terminal fusion to LexA. These constructs were used as a bait to screen a
random-primed Induced Macrophages cDNA library constructed into pP6. pB27 and pP6 derive
from the original pBTM116 (Vojtek and Hollenberg, 1995) and pGADGH (Bartel and Fields, 1995)
plasmids, respectively. Clones were screened using a mating approach with YHGX13 (Y187 ade2-
101::loxP-kanMX-loxP, mata) and L40DGal4 (mata) yeast strains as previously described (Fromont-
Racine et al., 1997). His + colonies were selected on a medium lacking tryptophan, leucine and histi-
dine. Because KHNYN-2 had some autoactivating activity, the selection medium was supplemented
with 10 mM 3-Aminotriazol.
The prey fragments of the positive clones were amplified by PCR and sequenced at their 5’ and
3’ junctions. The resulting sequences were used to identify the corresponding interacting proteins in
the GenBank database (NCBI) using a fully automated procedure. A confidence score (PBS, for Pre-
dicted Biological Score) was attributed to each interaction as previously described
(Formstecher et al., 2005). The PBS relies on two different levels of analysis. First, a local score
takes into account the redundancy and independency of prey fragments, as well as the distribution
of reading frames and stop codons in overlapping fragments. Second, a global score takes into
account the interactions found in all the screens performed at Hybrigenics using the same library.
This global score represents the probability of an interaction being nonspecific. The scores were
divided into six categories: A (highest confidence) to D (lowest confidence) plus category E that
demarcates interactions involving highly connected prey domains previously found several times in
screens performed on libraries derived from the same organism and category F that indicates highly
connected domains that have been confirmed as false-positives. The PBS scores have been shown to
positively correlate with the biological significance of interactions (Rain et al., 2001; Wojcik et al.,
2002).
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shows the average value of three independent experiments normalized to the value obtained for HeLa Control CRISPR cells co-transfected with pHIV-1
and pGFP. Data are represented as mean ± SD. Gag expression in the media as well as Gag, Hsp90, Env, Actin, KHNYN-FLAG and GFP-FLAG
expression in the cell lysates was detected using quantitative immunoblotting (B). (C–D) HeLa KHNYN-G1 CRISPR clone B cells were transfected with
500 ng pHIV-1 or pHIV-1EnvCpG86-561, 468.75 ng of pGFP-FLAG and 31.25 ng of pKHNYN-1-CRG1-FLAG expressing either wild-type or mutant proteins.
Culture supernatants from the cells were used to infect TZM-bl reporter cells (C). Each point shows the average value of seven independent
experiments normalized to the value obtained for HeLa Control CRISPR cells co-transfected with pHIV-1 and pGFP. Data are represented as
mean ± SD. *p<0.05 as determined by a two-tailed unpaired t-test. p-Values for HIV-1EnvCpG86-561 with KHNYN-1-CRG1 versus DKH-KHNYN-1-CGR1,
D443N-KHNYN-1-CGR1 and D524A/D525A-KHNYN-1-CGR1 are 2.56  10 5, 1.95  10 4, and 2.12  10 4, respectively. Gag expression in the media
as well as Gag, Hsp90, Env, Actin, KHNYN-FLAG and GFP-FLAG expression in the cell lysates was detected using quantitative immunoblotting (D).
DOI: https://doi.org/10.7554/eLife.46767.017
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Transfections
HeLa and HEK293T cells were grown to 70% confluence in six-well plates. HeLa cells were trans-
fected according to the manufacturer’s instructions using TransIT-LT1 (Mirus) at the ratio of 3 mL
TransIT- LT1 to 1 mg DNA. HEK293T cells were transfected according to the manufacturer’s instruc-
tions using PEI (1 mg/mL) (Sigma-Aldrich) at the ratio of 4 mL PEI to1 mg DNA. For the HIV-1 experi-
ments, 0.5 mg pHIV-1 and the designated amount of pKHNYN-FLAG, pGFP-FLAG or pGFP
(Swanson et al., 2010) were transfected for a total of 1 mg DNA. For the MLV experiments, 0.65 mg
pMLV, 0.25 mg pCR3.1 2.87 Vpu and 0.10 mg pGFP were transfected. The transfection medium was
replaced with fresh medium after a 6 hr incubation (HEK293T) or 24 hr incubation (HeLa).
Analysis of protein expression by immunoblotting
HeLa cells were seeded on six-well plates and transfected the following day with as described
above. Approximately 48 hr post-transfection, HeLa cells were lysed in radioimmunoprecipitation
assay (RIPA) buffer (150 mM NaCl, 1 mM EDTA, 1% Triton X-100, 1% sodium deoxycholate, 0.1%
SDS, 10 mM Tris–HCl pH 7.5) supplemented with complete protease inhibitor (Roche) and sheared
using a 0.25G needle. Media was filtered through a 0.45 mM filter and virions were pelleted for 2 hr
at 20,000 x g through a 20% sucrose cushion in phosphate-buffered saline (PBS) solution. The pellet
was resuspended in 2X loading buffer (60 mM Tris–HCl pH 6.8, 2% sodium dodecyl sulfate (SDS),
10% glycerol, 10% b-mercaptoethanol, 0.1% bromophenol blue). Cell lysates and virions were
resolved by 10% SDS-polyacrylamide gel electrophoresis (PAGE), transferred to a nitrocellulose
membrane (GE Healthcare) and blocked in 1% non-fat milk in PBS with 0.1% Tween 20 (Fischer Bio-
reagents). Primary antibodies were incubated for 2 hr at room temperature. After washing in PBS,
blots were incubated for 1 hr with the appropriate secondary antibody. Bound antibodies were visu-
alized on the LI-COR (Odyssey Fc) measuring the immunofluorescence or using Amersham ECL
Prime Western Blotting Detection reagent (GE Lifesciences) for HRP-linked antibodies using an
ImageQuant (LAS4000 Mini). For the co-immunoprecipitation experiments, lysates were resolved
using precast Mini-PROTEAN TGX gels 8–16% gradient gels (Bio-Rad) and transferred to nitrocellu-
lose membranes (Bio-Rad). Antibodies used in study were 1:50 HIV- one anti-
p24Gag (Chesebro et al., 1992), 1:3000 anti-HIV-1 gp160/120 Rabbit (ADP421; Centralized Facility
for AIDS Reagents (CFAR)), 1:10,0000 anti-HSP90 (sc7947, Santa Cruz Biotechnology), 1:5000 anti-
HSP90 Rabbit (GeneTex, GTX109753), 1:4000 anti-HSP90 Mouse (SantaCruz, sc-515081), 1:5000
anti-ZAP (Abcam, ab154680), 1:1000 anti-b-Actin Mouse (Sigma, A2228), 1:2500 anti-DYKDDDDK
(Rabbit) (Cell Signaling, 14793), 1:2500 anti-FLAG (Mouse) (Sigma, F1804), 1:2500 anti-FLAG (Rabbit)
(Sigma, F7425), 1:10000 anti-TRIM25 (Abcam, ab167154), 1:10000 anti-MLV p30 (Rat) (ATCC CRL-
1912) (Chesebro et al., 1983), 1:10,000 Dylight 800- conjugated secondary antibodies (Cell Signal-
ing Technology, 5151S and 5257S), 1:5000 anti-rabbit HRP (Cell Signaling Technology, 7074), 1:5000
anti-mouse HRP (Cell Signaling Technology, 7076), 1:4000 anti-rabbit IRDye 800CW (LI-COR, 926–
32211) or 1:4000 anti-mouse IRDye 680RD (LI-COR, 926–68070).
TZM-bl infectivity assay
Media was recovered approximately 48 hr post-transfection and cell-free virus stocks were gener-
ated by filtering the media through 0.45 mM filters (Millipore). The TZM-bl indicator cell line was
used to quantify the amount of infectious virus (Derdeyn et al., 2000; Platt et al., 1998; Wei et al.,
2002). TZM-bl cells were seeded at 70% confluency in 24-well plates and infected by overnight incu-
bation with virus stocks. 48 hr post infection, the cells were lysed and infectivity was measured by
analyzing b-galactosidase expression using the Galacto-Star System following manufacturer’s instruc-
tions (Applied Biosystems). b-galactosidase activity was quantified as relative light units per second
using a PerkinElmner Luminometer.
Immunoprecipitation assays
HEK293T cells in six-well plates were transfected with 800 ng of pKHNYN-1-FLAG, pKHNYN-2-
FLAG, pGFP-FLAG as a control using 3 mL TransIT-LT1 per 1 mg of DNA added. For the experiments
in which lysates were treated with Ribonuclease A (RNase A), 500 ng of pHA-ZAP-L (Kerns et al.,
2008) was also added. The cells were lysed on ice in lysis buffer (0.5% NP-40, 150 mM KCl, 10 mM
HEPES pH 7.5, 3 mM MgCl2) supplemented with complete EDTA-free Protease inhibitor cocktail
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tablets (Sigma-Aldrich), 10 mM N-Ethylmaleimide (Sigma-Aldrich) and PhosSTOP tablets (Sigma-
Aldrich). The lysates were sonicated and then centrifugated at 20,000 x g for 5 min at 4˚C. 50 ml of
the post-nuclear supernatants was saved as the input lysate and 450 ml were incubated with either
18 mg of anti-Flag antibody (Sigma-Aldrich, F7425) or 4.275 mg of anti-ZAP antibody (Abcam) for
one hour at 4˚C with rotation. Protein G Dynabeads (Invitrogen) were then added and incubated for
3 hr at 4˚C with rotation. The lysates were then washed four times with wash buffer (0.05% NP-40,
150 mM KCl, 10 mM HEPES pH 7.5, 3 mM MgCl2) before bound proteins were eluted with Laemmli
buffer and boiled for 10 min. When indicated, RNase A (Sigma-Aldrich) was added to the post-
nuclear supernatant and incubated for 30 min at 37˚C. Protein expression was analyzed via western
blot as described above.
RNA purification and quantitative RT-PCR
Total RNA was isolated from transfected HeLa cells using a QIAGEN RNeasy kit accordingly with the
manufacturer’s instructions. Viral RNA was extracted from cell supernatants using a QIAGEN
QIAamp Viral mini kit accordingly with the manufacturer’s instructions. 500 ng of purified cellular
RNA was reverse transcribed using random hexamer primers and a High-Capacity cDNA Reverse
Transcription kit (Applied Biosystems). Quantitative PCR was performed using a QuantiStudio 5 Sys-
tem (Thermo Fisher). For genomic RNA and nef mRNA in the cell lysate, the HIV-1 RNA abundance
was normalized to GAPDH levels using the GAPDH Taqman Assay (Applied Biosystems, Cat#
Hs99999905_m1). For the genomic RNA in the media, absolute quantification was determined using
a standard curve of the HIV-1 provirus DNA plasmid. The genomic RNA primers were GGCCAGG-
GAATTTTCTTCAGA/TTGTCTCTTCCCCAAACCTGA (forward/reverse) and the probe was FAM-
ACCAGAGCCAACAGCCCCACCAGA-TAMRA. The nef mRNA primers were GGCGGCGAC
TGGAAGAAGC/GATTGGGAGGTGGGTTGCTTTG-3’ (forward/reverse) (Jablonski and Caputi,
2009).
Microscopy
Cells were seeded on 24-well plates on coverslips pre-treated with poly-lysine. HEK293T cells
expressing a control guide RNA targeting the LacZ gene or a guide RNA targeting ZAP were trans-
fected with 250 ng of pKHNYN-FLAG. 24 hr post-transfection, the cells were fixed with 4% parafor-
maldehyde for 15 min at room temperature, washed with PBS, and then washed with 10 mM
glycine. The cells were then permeabilized for 15 min with 1% BSA and 0.1% Triton-X in PBS. Mouse
anti-FLAG (1:500) and rabbit anti-ZAP (1:500) antibodies were diluted in PBS/0.01% Triton-X and the
cells were stained for 1 hr at room temperature. The cells were then washed three times in PBS/
0.01% Triton-X and incubated with Alexa Fluor 594 anti-mouse and Alexa Fluor 488 anti-rabbit anti-
bodies (Molecular Probes, 1:500 in PBS/0.01% Triton-X) for 45 min in the dark. Finally, the coverslips
were washed three times with PBS/0.01% Triton-X and then mounted on slides with Prolong Dia-
mond Antifade Mountant with DAPI (Invitrogen). Imaging was performed on a Nikon Eclipse Ti
Inverted Microscope, equipped with a Yokogawa CSU/X1-spinning disk unit, under 60-100x objec-
tives and laser wavelengths of 405 nm, 488 nm and 561 nm. Image processing and co-localization
analysis was performed with NIS Elements Viewer and Image J (Fiji) software.
Analysis of CpG frequency in HIV-1, MLV and Sindbis virus
The ‘analyze base composition’ tool in MacVector was used to calculate the CpG frequencies for the
HIV-1NL4-3 (NCBI accession number M19921) genomic RNA, MLV genomic RNA (J02255) and Sindbis
virus (NC_001547). The CpG frequencies were calculated using the following formula: number of
CpG occurrences / (frequency of C * frequency of G) where frequency of the base is the number of
occurrences of the base/total number of bases in sequence.
Sindbis virus replication assays
Sindbis virus (SINV), a kind gift from Penny Powell (University of East Anglia), was expanded and
titrated in BHK-21 cells (Mazzon et al., 2018). Control, ZAP, TRIM25 or KHNYN HeLa cells were
plated at 100,000 cells/well in 12-well plates. The following day, the cells were infected with Sindbis
virus at a multiplicity of infection of 0.005 pfu/cell. After 90 mins, the infectious media was removed,
the cells were washed once with PBS and then incubated with 1 ml of media. The media from the
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infected cells was harvested at 8, 16, 24 and 32 hr post-infection. 100 ml of serial diluted media from
the cells (from 10 1 to 10 8) were added onto BHK-21 cells in 96 well plates (8,000 cells/well plated
the previous day). After 90 min, the media was removed and replaced with fresh media. An MTT
assay was carried out on each plate 24 hr later. Briefly, 20 ml of 50 mg/ml Thiazolyl Blue Tetrazolium
Bromide in PBS were added onto the cell media for 2 hr at 37˚C, after which the supernatant is
removed and replaced with 40 ml of a 1:1 solution of isopropanol and DMSO. 20 min later, 35 ml of
the supernatant are transferred onto a 96 well plate and signal read at 570 nm. Values from this
assay were used to determine the TCID50 and pfu/ml.
Statistical analysis
Statistical significance was determined using unpaired two-tailed t tests calculated using Microsoft
excel software. Data are represented as mean ± SD. Significance was ascribed to p values p < 0.05.
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